The goal is to collect clinical data and skin and blood samples from 3,000 patients to gain new insights into some of the most common skin diseases, such as psoriasis and eczema. Patients will be followed closely over a period of a minimum of five years.
The program provides a unique opportunity to collect data and skin and blood samples from the same patients over several years, creating new scientific possibilities and ultimately leading to more effective treatments.
The project group uses Danish National Genome Center's infrastructure to store data, analyze the patient population and investigate correlations between the clinical data and molecular signatures. The project aims to increase the clinical, genetic and molecular biological knowledge that can support individualized patient processes and describe the importance of genetic and epigenetic variants for treating the patients.